BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 20708777)

  • 1. Association of DNA polymorphisms within the CYP11B2/CYP11B1 locus and postoperative hypertension risk in the patients with aldosterone-producing adenomas.
    Wang B; Zhang G; Ouyang J; Deng X; Shi T; Ma X; Li H; Ju Z; Wang C; Wu Z; Liu S; Zhang X
    Urology; 2010 Oct; 76(4):1018.e1-7. PubMed ID: 20708777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms in CYP11B2 and CYP11B1 genes associated with primary hyperaldosteronism.
    Zhang GX; Wang BJ; Ouyang JZ; Deng XY; Ma X; Li HZ; Wu Z; Liu SL; Xu H; Zhang X
    Hypertens Res; 2010 May; 33(5):478-84. PubMed ID: 20339375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphic variation of CYP11B2 predicts postoperative resolution of hypertension in patients undergoing adrenalectomy for aldosterone-producing adenomas.
    Wang W; Hu WL; Zhang LC; Xiao YS; Liu J; Bin C
    Int J Urol; 2012 Sep; 19(9):813-20. PubMed ID: 22650983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation analysis of CYP11B1 and CYP11B2 in patients with increased 18-hydroxycortisol production.
    Nicod J; Dick B; Frey FJ; Ferrari P
    Mol Cell Endocrinol; 2004 Feb; 214(1-2):167-74. PubMed ID: 15062555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term results of adrenalectomy in patients with aldosterone-producing adenomas: multivariate analysis of factors affecting unresolved hypertension and review of the literature.
    Lumachi F; Ermani M; Basso SM; Armanini D; Iacobone M; Favia G
    Am Surg; 2005 Oct; 71(10):864-9. PubMed ID: 16468537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].
    Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z
    Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical treatment as an alternative to adrenalectomy in patients with aldosterone-producing adenomas.
    Karagiannis A; Tziomalos K; Kakafika AI; Athyros VG; Harsoulis F; Mikhailidis DP
    Endocr Relat Cancer; 2008 Sep; 15(3):693-700. PubMed ID: 18586836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of polymorphisms in the gene encoding aldosterone synthase (CYP11B2) on steroid synthesis and blood pressure regulation.
    Connell JM; Fraser R; MacKenzie SM; Friel EC; Ingram MC; Holloway CD; Davies E
    Mol Cell Endocrinol; 2004 Mar; 217(1-2):243-7. PubMed ID: 15134824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic screening for glucocorticoid-remediable aldosteronism (GRA): experience of three clinical centres in Poland.
    Adler G; Widecka K; Peczkowska M; Dobrucki T; Placha G; Drozd R; Parczewski M; Januszewicz A; Gaciong Z; Ciechanowicz A
    J Appl Genet; 2005; 46(3):329-32. PubMed ID: 16110193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of laparoscopic adrenalectomy for hyperaldosteronism.
    Pang TC; Bambach C; Monaghan JC; Sidhu SB; Bune A; Delbridge LW; Sywak MS
    ANZ J Surg; 2007 Sep; 77(9):768-73. PubMed ID: 17685956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in CYP11B1 gene converting 11beta-hydroxylase into an aldosterone-producing enzyme are not present in aldosterone-producing adenomas.
    Pilon C; Mulatero P; Barzon L; Veglio F; Garrone C; Boscaro M; Sonino N; Fallo F
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4228-31. PubMed ID: 10566677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in aldosterone synthase gene of Milan hypertensive rats: phenotypic consequences.
    Lloyd-MacGilp SA; Torielli L; Bechtel S; Tripodi G; Gomez-Sanchez CE; Zagato L; Bernhardt R; Kenyon CJ
    Am J Physiol Endocrinol Metab; 2002 Mar; 282(3):E608-17. PubMed ID: 11832364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and biochemical characteristics of normotensive patients with primary aldosteronism: a comparison with hypertensive cases.
    Médeau V; Moreau F; Trinquart L; Clemessy M; Wémeau JL; Vantyghem MC; Plouin PF; Reznik Y
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):20-8. PubMed ID: 18284637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and factors of post-adrenalectomy hyperkalemia in patients with aldosterone producing adenoma.
    Chiang WF; Cheng CJ; Wu ST; Sun GH; Lin MY; Sung CC; Lin SH
    Clin Chim Acta; 2013 Sep; 424():114-8. PubMed ID: 23727469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro release of aldosterone and cortisol in human adrenal adenomas correlates to mRNA expression of steroidogenic enzymes for genes CYP11B2 and CYP17.
    Enberg U; Farnebo LO; Wedell A; Gröndal S; Thorén M; Grimelius L; Kjellman M; Bäckdahl M; Hamberger B
    World J Surg; 2001 Jul; 25(7):957-66. PubMed ID: 11572038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary aldosterone-to-active-renin ratio: a useful tool for predicting resolution of hypertension after adrenalectomy in patients with aldosterone-producing adenomas.
    Mourad JJ; Girerd X; Milliez P; Lopez-Sublet M; Lejeune S; Safar ME
    Am J Hypertens; 2008 Jul; 21(7):742-7. PubMed ID: 18443567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PRKACA Somatic Mutations Are Rare Findings in Aldosterone-Producing Adenomas.
    Rhayem Y; Perez-Rivas LG; Dietz A; Bathon K; Gebhard C; Riester A; Mauracher B; Gomez-Sanchez C; Eisenhofer G; Schwarzmayr T; Calebiro D; Strom TM; Reincke M; Beuschlein F
    J Clin Endocrinol Metab; 2016 Aug; 101(8):3010-7. PubMed ID: 27270477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiological roles of the adrenal renin-angiotensin system in patients with primary aldosteronism.
    Oda N; Takeda Y; Zhu A; Usukura M; Yoneda T; Takata H; Mabuchi H
    Hypertens Res; 2006 Jan; 29(1):9-14. PubMed ID: 16715648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of kidney function with residual hypertension after treatment of aldosterone-producing adenoma.
    ; Wu VC; Chueh SC; Chang HW; Lin LY; Liu KL; Lin YH; Ho YL; Lin WC; Wang SM; Huang KH; Hung KY; Kao TW; Lin SL; Yen RF; Chen YM; Hsieh BS; Wu KD
    Am J Kidney Dis; 2009 Oct; 54(4):665-73. PubMed ID: 19628318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYP11B2 gene haplotypes independently and in concurrence with aldosterone and aldosterone to renin ratio increase the risk of hypertension.
    Nejatizadeh A; Kumar R; Stobdan T; Goyal AK; Gupta M; Tyagi S; Jain SK; Pasha MA
    Clin Biochem; 2010 Jan; 43(1-2):136-41. PubMed ID: 19786005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.